ГоловнаArchive of numbers2020Volume 28, issue 4 (105)Psychotic disorders in COVID-19: mechanisms of development, clinical and treatment features
Title of the article | Psychotic disorders in COVID-19: mechanisms of development, clinical and treatment features | ||||
Authors |
Yuryeva Liudmyla Shornikov Andrii |
||||
In the section | PROBLEMATIC AND REVIEW ARTICLES | ||||
Year | 2020 | Issue | Volume 28, issue 4 (105) | Pages | 13-17 |
Type of article | Scientific article | Index UDK | 616.89-02-022:578.834-616-092.11-616.89-02-07 | Index BBK | - |
Abstract |
The purpose of this review was
to study the mechanisms of development,
clinical features and treatment
of psychotic disorders during the disease
caused by the SARS-CoV-2 virus. In the
first part of the review, especial attention
was paid to the available literature
data on the mechanisms of development
of mental disorders in COVID-19.
Among the main pathogenetic mechanisms
of the onset of psychotic disorders
in coronavirus infections, there
are direct effects of a viral infection
(including a brain infection), cerebrovascular
diseases, hypoxia, an immunological
response, the consequences
of medical interventions, social isolation,
the psychological impact of a severe
and potentially fatal illness, fears of infecting
another’s and stigmatization.
The second part of the publication
is devoted to a review of clinical studies
and syndromokinesis in infectious
and coronavirus psychoses. Particular
attention is paid to delirious syndrome,
including pharmacogenic delirium and
antibiotic-associated encephalopathy.
The article describes the features
of therapy for psychotic disorders
in COVID-19, taking into account
drug‑drug interactions and the effect
on the cardiovascular and respiratory
systems.
The analyzed literature allows
us to make a reasonable conclusion
that the management of coronavirus
psychoses should be aimed at treating
the underlying disease while eliminating
psychotic symptoms with antipsychotics
while ensuring maximum safety of psychopharmacotherapy.
|
||||
Key words | COVID-19, pathogenesis, infectious psychosis, delirium, treatment | ||||
Access to full text version of the article pdf | download | ||||
Bibliography | 1. Rogers, J. P., Chesney, E., Oliver, D., Pollak, T. A., McGuire, P., Fusar-Poli, P., Zandi, M. S., Lewis, G., & David, A. S. (2020). Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: A systematic review and meta-analysis with comparison to the COVID-19 pandemic. The Lancet. Psychiatry, 7(7), 611. https://doi.org/10.1016/S2215-0366(20)30203-0 2. Taquet, M., Luciano, S., Geddes, J. R., & Harrison, P. J. (2020). Bidirectional associations between COVID-19 and psychiatric disorder: Retrospective cohort studies of 62 354 COVID-19 cases in the USA. The Lancet Psychiatry. https://doi.org/10.1016/S2215-0366(20)30462-4 3. Ji, W., Huh, K., Kang, M., Hong, J., Bae, G. H., Lee, R., Na, Y., Choi, H., Gong, S. Y., Choi, Y.-H., Ko, K.-P., Im, J.-S., & Jung, J. (2020). Effect of Underlying Comorbidities on the Infection and Severity of COVID-19 in Korea: A Nationwide Case-Control Study. Journal of Korean Medical Science, 35(25). https://doi.org/10.3346/jkms.2020.35.e237 4. Yang, H., Chen, W., Hu, Y., Chen, Y., Zeng, Y., Sun, Y., Ying, Z., He, J., Qu, Y., Lu, D., Fang, F., Valdimarsdóttir, U. A., & Song, H. (2020). Pre-pandemic psychiatric disorders and risk of COVID-19: A UK Biobank cohort analysis. The Lancet Healthy Longevity, 1(2), e69–e79. https://doi.org/10.1016/S2666-7568(20)30013-1 5. Severance, E. G., Dickerson, F. B., Viscidi, R. P., Bossis, I., Stallings, C. R., Origoni, A. E., Sullens, A., & Yolken, R. H. (2011). Coronavirus Immunoreactivity in Individuals With a Recent Onset of Psychotic Symptoms. Schizophrenia Bulletin, 37(1), 101–107. https://doi.org/10.1093/schbul/sbp052 6. Chacko, M., Job, A., Caston, F., George, P., Yacoub, A., & Cáceda, R. (2020). COVID-19-Induced Psychosis and Suicidal Behavior: Case Report. SN Comprehensive Clinical Medicine. https://doi.org/10.1007/s42399-020-00530-7 7. Brown, E., Gray, R., Lo Monaco, S., O’Donoghue, B., Nelson, B., Thompson, A., Francey, S., & McGorry, P. (2020). The potential impact of COVID-19 on psychosis: A rapid review of contemporary epidemic and pandemic research. Schizophrenia Research, 222, 79–87. https://doi.org/10.1016/j.schres.2020.05.005 8. Compton, M. T., & Shim, R. S. (2015). The Social Determinants of Mental Health. FOCUS, 13(4), 419–425. https://doi.org/10.1176/appi.focus.20150017 9. Anglin, D. M., Galea, S., & Bachman, P. (2020). Going Upstream to Advance Psychosis Prevention and Improve Public Health. JAMA Psychiatry, 77(7), 665–666. https://doi.org/10.1001/jamapsychiatry.2020.0142 10. Ferrando, S. J., Klepacz, L., Lynch, S., Tavakkoli, M., Dornbush, R., Baharani, R., Smolin, Y., & Bartell, A. (2020). COVID-19 Psychosis: A Potential New Neuropsychiatric Condition Triggered by Novel Coronavirus Infection and the Inflammatory Response? Psychosomatics, 61(5), 551–555. https://doi.org/10.1016/j.psym.2020.05.012 11. Troyer, E. A., Kohn, J. N., & Hong, S. (2020). Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain, Behavior, and Immunity, 87, 34–39. https://doi.org/10.1016/j.bbi.2020.04.027 12. Mirza, J., Ganguly, A., Ostrovskaya, A., Tusher, A., & Viswanathan, R. (2020). Command Suicidal Hallucination as Initial Presentation of Coronavirus Disease 2019 (COVID-19): A Case Report. Psychosomatics, 61(5), 561–564. https://doi.org/10.1016/j.psym.2020.05.022 13. Wu, Y., Xu, X., Chen, Z., Duan, J., Hashimoto, K., Yang, L., Liu, C., & Yang, C. (2020). Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain, Behavior, and Immunity, 87, 18–22. https://doi.org/10.1016/j.bbi.2020.03.031 14. Cheng, S. K.-W., Tsang, J. S.-K., Ku, K.-H., Wong, C.-W., & Ng, Y.-K. (2004). Psychiatric complications in patients with severe acute respiratory syndrome (SARS) during the acute treatment phase: A series of 10 cases. The British Journal of Psychiatry, 184(4), 359–360. https://doi.org/10.1192/bjp.184.4.359 15. Smith, C. M., Komisar, J. R., Mourad, A., & Kincaid, B. R. (2020). COVID-19-associated brief psychotic disorder. BMJ Case Reports, 13(8), e236940. https://doi.org/10.1136/bcr-2020-236940 16. Yureva, L. N., & Shusterman, T. Y. (2020). Pandemyia COVID-19: Rysky dlia psykholohycheskoho blahopoluchyia y psykhycheskoho zdorovia. Ukrainskyi visnyk psykhonevrolohii, 28(2), 5–10. https://doi.org/10.36927/2079-0325-V28-is2-2020-1 17. Abaturov, O. Ye., Kramarov, S. O., & Yurieva, L. M. (Eds.). (2020). Likuvannia ta profilaktyka COVID-19. Okhorona psykhichnoho zdorovia v umovakh pandemii. Lviv: Vydavets Marchenko T.V., 2020. 252 p. 18. Beach, S. R., Praschan, N. C., Hogan, C., Dotson, S., Merideth, F., Kontos, N., Fricchione, G. L., & Smith, F. A. (2020). Delirium in COVID-19: A case series and exploration of potential mechanisms for central nervous system involvement. General Hospital Psychiatry, 65, 47–53. https://doi.org/10.1016/j.genhosppsych.2020.05.008 19. Bhattacharyya, S., Darby, R. R., Raibagkar, P., Gonzalez Castro, L. N., & Berkowitz, A. L. (2016). Antibiotic-associated encephalopathy. Neurology, 86(10), 963–971. https://doi.org/10.1212/WNL.0000000000002455 20. Levenson, J. L. (2018). The American Psychiatric Association Publishing Textbook of Psychosomatic Medicine and Consultation-Liaison Psychiatry (Third Edition). American Psychiatric Association Publishing. https://doi.org/10.1176/appi.books.9781615371990. 21. Asselman, V., Thienemann, F., Pepper, D. J., Boulle, A., Wilkinson, R. J., Meintjes, G., & Marais, S. (2010). Central nervous system disorders after starting antiretroviral therapy in South Africa: AIDS, 24(18), 2871–2876. https://doi.org/10.1097/QAD.0b013e328340fe76. 22. Gatch, M. B., Kozlenkov, A., Huang, R.-Q., Yang, W., Nguyen, J. D., González-Maeso, J., Rice, K. C., France, C. P., Dillon, G. H., Forster, M. J., & Schetz, J. A. (2013). The HIV Antiretroviral Drug Efavirenz has LSD-Like Properties. Neuropsychopharmacology, 38(12), 2373–2384. https://doi.org/10.1038/npp.2013.135. 23. Huremović, D. (Ed.). (2019). Psychiatry of Pandemics: A Mental Health Response to Infection Outbreak. Springer International Publishing. https://doi.org/10.1007/978-3-030-15346-5. 24. Huarcaya-Victoria, J., Meneses-Saco, A., & Luna-Cuadros, M. A. (2020). Psychotic symptoms in COVID-19 infection: A case series from Lima, Peru. Psychiatry Research, 293, 113378. https://doi.org/10.1016/j.psychres.2020.113378. 25. Valdés-Florido, M. J., López-Díaz, Á., Palermo-Zeballos, F. J., Martínez-Molina, I., Martín-Gil, V. E., Crespo-Facorro, B., & Ruiz-Veguilla, M. (2020). Reactive psychoses in the context of the COVID-19 pandemic: Clinical perspectives from a case series. Revista De Psiquiatria Y Salud Mental, 13(2), 90–94. https://doi.org/10.1016/j.rpsm.2020.04.009. 26. Duan, L., Shao, X., Wang, Y., Huang, Y., Miao, J., Yang, X., & Zhu, G. (2020). An investigation of mental health status of children and adolescents in china during the outbreak of COVID-19. Journal of Affective Disorders, 275, 112–118. https://doi.org/10.1016/j.jad.2020.06.029. 27. Szcześniak, D., Gładka, A., Misiak, B., Cyran, A., & Rymaszewska, J. (2021). The SARS-CoV-2 and mental health: From biological mechanisms to social consequences. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 104, 110046. https://doi.org/10.1016/j.pnpbp.2020.110046 28. Mawhinney, J. A., Wilcock, C., Haboubi, H., & Roshanzamir, S. (2020). Neurotropism of SARS-CoV-2: COVID-19 presenting with an acute manic episode. BMJ Case Reports CP, 13(6), e236123. https://doi.org/10.1136/bcr-2020-236123 29. Yuryeva, L.M. (Ed.). (2019). Orhanichni psykhichni rozlady: Diahnostyka, reabilitatsiia ta profilaktyka. Nova ideolohiia , 2019. 124 p. 30. Li, P., Wang, Y., Peppelenbosch, M. P., Ma, Z., & Pan, Q. (2020). Systematically comparing COVID-19 with 2009 influenza pandemic for hospitalized patients. International Journal of Infectious Diseases. https://doi.org/10.1016/j.ijid.2020.11.127 31. González-Rodríguez, A., & Labad, J. (2020). Mental health in times of COVID: Thoughts after the state of alarm. Medicina Clinica (English Ed.), 155(9), 392–394. https://doi.org/10.1016/j.medcle.2020.07.007 32. Voloshyn, P. V., Maruta, N. O., Linskyi, I. V., Zilberblat, H. M., Kutikov, O. Ye., Minko, O. I., Mishyiev, V. D., Pidkorytov, V. S., & Shestopalova, L. F. (2020). Rekomendatsii Asotsiatsii nevrolohiv, psykhiatriv i narkolohiv Ukrainy shchodo nadannia psykhiatrychnoi dopomohy v period epidemii COVID-19. https://inpn.org.ua/news/34
|